2nd Quarter - Report

W STRATEGIES, LLC for BIOGEN

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 9: Innovation Act, including provisions to reform the Inter Partes Review process at the Patent and Trademark Office (PTO). S. 632: Strong Patents Act. S. 1137: PATENT Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1137 (114th), H.R. 9 (114th), S. 632 (114th)

Health Issues HCR

Education about the value of innovative new medicines. H.R. 6: 21st Century Cures Act. Legislative efforts in Senate HELP Committee to promote medical innovation for patients.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.